Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanism

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 812-818

  Nicolas, Alexandra ^a   Cathelin, Dominique ^a   Larmonier, Nicolas ^b   Fraszczak, Jennifer ^a   Puig, Pierre Emmanuel ^a   Bouchot, André ^a   Bateman, Andrew ^c   Solary, Eric ^a   Bonnotte, Bernard ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANZYME; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL COMMUNICATION; CELL CONTACT; CELL DEATH; CELL INFILTRATION; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL; ANIMAL; BONE MARROW CELL; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; NEOPLASM; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DEATH; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; LIPOPOLYSACCHARIDES; NEOPLASMS; NITRIC OXIDE; RATS;

EID: 34548780921     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.812     Document Type: Article

References (46)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. 2+-dependent mechanism. J. Exp. Med. 186: 467-472.
3. Chapoval, A. I., K. Tamada, and L. Chen. 2000. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95:2346-2351.
4. Manna, P. P., and T. Mohanakumar. 2002. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro. J. Leukocyte Biol. 72: 312-320.
5. Vanderheyde, N., E. Aksoy, Z. Amraoui, P. Vandenabeele, M. Goldman, and F. Willems. 2001. Tumoricidal activity of monocyte-derived dendritic cells: evidence for a caspase-8-dependent, Fas-associated death domain-independent mechanism. J. Immunol. 167: 3565-3569.
6. Yang, R., D. Xu, A. Zhang, and A. Gruber. 2001. Immature dendritic cells kill ovarian carcinoma cells by a Fas/FasL pathway, enabling them to sensitize tumor-specific CTLs. Int. J. Cancer. 94: 407-413.
7. + rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. J. Immunol. 175: 2408-2417.
8. Chen, L., E. Calomeni, J. Wen, K. Ozato, R. Shen, and J. X. Gao. 2007. Natural killer dendritic cells are an intermediate of developing dendritic cells. J. Leukocyte Biol. 81: 1422-1423.
9. Schmitz, M., S. Zhao, Y. Deuse, K. Schakel, R. Wehner, H. Wohner, K. Holig, F. Wienforth, A. Kiessling, M. Bornhauser, et al. 2005. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J. Immunol. 174: 4127-4134.
10. Shi, J., K. Ikeda, N. Fujii, E. Kondo, K. Shinagawa, F. Ishimaru, K. Kaneda, M. Tanimoto, X. Li, and Q. Pu. 2005. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci. 96: 127-133.
11. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183: 1789-1796.
12. +) dendritic cells to kill alloactivated T cells. Adv. Exp. Med. Biol. 417: 275-282.
13. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
14. Rensing-Ehl, A., K. Frei, R. Flury, B. Matiba, S. M. Mariani, M. Weller, P. Aebischer, P. H. Krammer, and A. Fontana. 1995. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25: 2253-2258.
15. Caignard, A., P. Genne, N. O. Olsson, R. Oriol, and F. Martin. 1990. F11C antigen: a membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma. Int. J. Cancer. 46: 633-639.
16. Martin, F., A. Caignard, J. F. Jeannin, A. Leclerc, and M. Martin. 1983. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer. 32: 623-627.
17. Grauer, O., G. Wohlleben, S. Seubert, A. Weishaupt, E. Kampgen, and R. Gold. 2002. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique. Histochem. Cell Biol. 117: 351-362.
18. Bonnotte, B., N. Favre, S. Reveneau, O. Micheau, N. Droin, C. Garrido, A. Fontana, B. Chauffert, E. Solary, and F. Martin. 1998. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ. 5: 480-487.
19. Larmonier, N., C. Billerey, C. Rebe, A. Parcellier, M. Moutet, A. Fromentin, G. Kroemer, C. Garrido, E. Solary, F. Martin, and B. Bonnotte. 2002. An atypical caspase-independent death pathway for an immunogenic cancer cell line. Oncogene 21: 6091-6100.
20. Bonnotte, B., N. Favre, M. Moutet, A. Fromentin, E. Solary, M. Martin, and F. Martin. 2000. Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes. J. Immunol. 164: 1995-2000.
21. Bonnotte, B., N. Larmonier, N. Favre, A. Fromentin, M. Moutet, M. Martin, S. Gurbuxani, E. Solary, B. Chauffert, and F. Martin. 2001. Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system. J. Immunol. 167: 5077-5083.
22. Larmonier, N., D. Merino, A. Nicolas, D. Cathelin, A. Besson, A. Bateman, E. Solary, F. Martin, E. Katsanis, and B. Bonnotte. 2006. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis 11: 1513-1524.
23. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
24. Fanger, N. A., C. R. Maliszewski, K. Schooley, and T. S. Griffith. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190: 1155-1164.
25. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
26. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
27. Voisine, C., F.-X. Hubert, B. Trinite, M. Heslan, and R. Josien. 2002. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J. Immunol. 169: 2284-2291.
28. Liu, S., Y. Yu, M. Zhang, W. Wang, and X. Cao. 2001. The Involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells. J. Immunol. 166: 5407-5415.
29. Virag, L., E. Szabo, P. Gergely, and C. Szabo. 2003. Peroxynitrite- induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140-141:113-124.
30. Kim, Y. M., C. A. Bombeck, and T. R. Billiar. 1999. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84: 253-256.
31. Guzik, T. J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54: 469-487.
32. Albina, J. E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukocyte Biol. 58: 643-649.
33. Denis, M. 1994. Human monocytes/macrophages: NO or no NO. J. Leukocyte Biol. 55: 682-684.
34. Murray, H. W., and R. F. Teitelbaum. 1992. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165: 513-517.
35. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167: 1358-1363.
36. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Bachus, et al. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195.
37. Diefenbach, A., H. Schindler, M. Rollinghoff, W. M. Yokoyama, and C. Bogdan. 1999. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284: 951-955.
38. Cifone, M. G., S. D'Alo, R. Parroni, D. Millimaggi, L. Biordi, S. Martinotti, and A. Santoni. 1999. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-γ production. Blood 93: 3876-3884.
39. Salvucci, O., J. P. Kolb, B. Dugas, N. Dugas, and S. Chouaib. 1998. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-α in human natural killer cells: relationship with the regulation of lytic activity. Blood 92: 2093-2102.
40. Schoedon, G., M. Schneemann, S. Hofer, L. Guerrero, N. Blau, and A. Schaffner. 1993. Regulation of the L-arginine-dependent and tetrahydrobiopterin- dependent biosynthesis of nitric oxide in murine macrophages. Eur. J. Biochem. 213: 833-839.
41. Vodovotz, Y., N. S. Kwon, M. Pospischil, J. Manning, J. Paik, and C. Nathan. 1994. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J. Immunol. 152: 4110-4118.
42. Sharara, A. I., D. J. Perkins, M. A. Misukonis, S. U. Chan, J. A. Dominitz, and J. B. Weinberg. 1997. Interferon (IFN)-α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-γ in vivo. J. Exp. Med. 186: 1495-1502.
43. Chaux, P., M. Moutet, J. Faivre, F. Martin, and M. Martin. 1996. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest. 74: 975-983.
44. Chaux, P., N. Favre, B. Bonnotte, M. Moutet, M. Martin, and F. Martin. 1997. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression: a role in the immune tolerance to antigenic tumors. Adv. Exp. Med. Biol. 417: 525-528.
45. Bonnotte, B., M. Crittenden, N. Larmonier, M. Gough, and R. G. Vile. 2004. MIP-3α transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity. J. Immunol. 173: 4929-4935.
46. 15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138.